Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ANVS stock hub

Annovis Bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ANVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

78.7M

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

ANVS

In the news

Latest news · ANVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-220.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-141.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ANVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001477845
Company name	Annovis Bio, Inc.
Country	United States
Country code	US
Cusip	03615A108
Employees	7
Employees Change	-8%
Employees Change Percent	-53.33
Enterprise value	$59.2M
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-01-29
Isin	US03615A1088
Last refreshed	2026-05-10
Market cap	$78.7M
Market cap category	Micro-Cap
Price	$2.28
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ANVS
Website	https://www.annovisbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-36.65%
P/B ratio	3.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-28.9M
Net Income Growth Years	0%
Profit Per Employee	$-4.1M
ROA	-106
Roa5y	-87.7
ROCE	-170.2
ROE	-220.6
Roe5y	-810.3
ROIC	-141.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	44.34%
Cagr3y	-45.82%
Cagr5y	-37.27%
EPS Growth Quarters	8
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$21.1M
Cash	$19.5M
Current Assets	$21.1M
Current Liabilities	$3.6M
Equity	$16.9M
Liabilities	$4.2M
Long Term Assets	$0
Long Term Liabilities	$595,000
Net Cash	$19.5M
Net Cash By Market Cap	$24.81
Net Cash Growth	85.11%
Net Debt Equity	$-1.16
Tangible Book Value	$16.9M
Tangible Book Value Per Share	$0.62
WACC	11.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.8
Net Working Capital	$-2.1M
Quick ratio	5.37
Working Capital	$17.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-67.97%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	44.3%
200-day SMA	2.66
3Y total return	-84.1%
50-day SMA	2.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.29%
All Time High	132
All Time High Change	-98.27%
All Time High Date	2021-07-23
All Time Low	1.11
All Time Low Change	105.41%
All Time Low Date	2025-04-09
ATR	0.18
Beta	1.26
Beta1y	2.03
Beta2y	2.69
Ch YTD	-34.1
High	2.35
High52	5.5
High52 Date	2025-11-28
High52ch	-58.55%
Low	2.25
Low52	1.48
Low52 Date	2025-05-12
Low52ch	54.05%
Ma50ch	3.07%
Premarket Change Percent	3.54
Premarket Price	$2.34
Premarket Volume	6,290
Price vs 200-day SMA	-14.19%
RSI	57.79
RSI Monthly	42.36
RSI Weekly	46.69
Sharpe ratio	0.84x
Sortino ratio	1.35
Total Return	-67.97%
Tr YTD	-34.1
Tr1m	0.44%
Tr1w	14%
Tr3m	-8.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.35
Operating Income	$-29.7M
Price target	$13.5
Price Target Change	$492

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,723,796%
Float Percent	86.08%
Shares Insiders	13.92%
Shares Institutions	15%
Shares Out	34,532,393
Shares Qo Q	29.94%
Shares Yo Y	67.97%
Short Float	16.02%
Short Ratio	4.27
Short Shares	13.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,129,975.5x
Bv Per Share	0.62
Ch1m	0.44
Ch1w	14
Ch1y	44.3
Ch3m	-8.43
Ch3y	-84.1
Ch5y	-90.29
Ch6m	14
Change	0.88%
Change From Open	-0.87
Close	2.26
Days Gap	1.77
Dollar Volume	1,686,392.9
Earnings Date	2026-05-22
EBIT	$-29.7M
EPS	$-1.4
F Score	2
Financing CF	34,600,125
Fiscal Year End	December
Founded	2,008
Ipr	-62
Iprfo	-65.61
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Ma150	2.73
Ma150ch	-16.36%
Ma20	1.95
Ma20ch	16.92%
Net CF	8,980,422
Next Earnings Date	2026-05-22
Open	2.3
Optionable	Yes
Position In Range	30
Post Close	2.28
Postmarket Change Percent	-0.43
Postmarket Price	$2.27
Pre Close	2.26
Price Date	2026-05-08
Ptbv Ratio	4.67
Relative Volume	0.65x
Share Based Comp	1,797,676
Tr6m	14%
Us State	Pennsylvania
Volume	739,646

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ANVS pay a dividend?

Capital-return profile for this ticker.

Performance

ANVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ANVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.0%

Float: +86.1% of shares outstanding

Insider ownership

+13.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ANVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.8

Neutral momentum band

Price vs 200-day MA

-14.2%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

0.84

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ANVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ANVS stock rating?

Annovis Bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ANVS analysis?

The full report lives at /stocks/ANVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ANVS?

The latest report frames ANVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ANVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.